Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury

Details for Australian Patent Application No. 2007257652 (hide)

Owner Novartis AG

Inventors Earnest, David Lewis

Agent Davies Collison Cave

Pub. Number AU-A-2007257652

PCT Pub. Number WO2007/146983

Priority 60/813,852 15.06.06 US

Filing date 13 June 2007

Wipo publication date 21 December 2007

International Classifications

A61K 31/19 (2006.01)

A61K 31/196 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4045 (2006.01)

A61K 31/405 (2006.01)

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4439 (2006.01)

A61K 31/5415 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

A61K 31/60 (2006.01) - Salicylic acid

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/146983 Priority application(s): WO2007/146983

8 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007257667-Nanoparticulate kinase inhibitor formulations

2007257650-2-anilino-4-(heterocyclic)amino-pyrimidi nes as inhibitors of protein kinase Calpha